1. Home
  2. TNK vs MDXG Comparison

TNK vs MDXG Comparison

Compare TNK & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNK
  • MDXG
  • Stock Information
  • Founded
  • TNK 2007
  • MDXG 2006
  • Country
  • TNK Bermuda
  • MDXG United States
  • Employees
  • TNK N/A
  • MDXG N/A
  • Industry
  • TNK Marine Transportation
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • TNK Consumer Discretionary
  • MDXG Health Care
  • Exchange
  • TNK Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • TNK 1.6B
  • MDXG 877.4M
  • IPO Year
  • TNK 2007
  • MDXG N/A
  • Fundamental
  • Price
  • TNK $44.04
  • MDXG $6.80
  • Analyst Decision
  • TNK Buy
  • MDXG Strong Buy
  • Analyst Count
  • TNK 3
  • MDXG 2
  • Target Price
  • TNK $50.67
  • MDXG $12.50
  • AVG Volume (30 Days)
  • TNK 577.7K
  • MDXG 755.3K
  • Earning Date
  • TNK 07-31-2025
  • MDXG 07-30-2025
  • Dividend Yield
  • TNK 4.54%
  • MDXG N/A
  • EPS Growth
  • TNK N/A
  • MDXG N/A
  • EPS
  • TNK 9.52
  • MDXG 0.27
  • Revenue
  • TNK $1,092,689,000.00
  • MDXG $352,375,000.00
  • Revenue This Year
  • TNK N/A
  • MDXG $9.55
  • Revenue Next Year
  • TNK N/A
  • MDXG $11.43
  • P/E Ratio
  • TNK $4.63
  • MDXG $24.67
  • Revenue Growth
  • TNK N/A
  • MDXG 5.34
  • 52 Week Low
  • TNK $33.35
  • MDXG $5.47
  • 52 Week High
  • TNK $66.25
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • TNK 48.72
  • MDXG 60.83
  • Support Level
  • TNK $42.42
  • MDXG $6.57
  • Resistance Level
  • TNK $44.79
  • MDXG $7.05
  • Average True Range (ATR)
  • TNK 1.48
  • MDXG 0.24
  • MACD
  • TNK -0.01
  • MDXG 0.11
  • Stochastic Oscillator
  • TNK 47.59
  • MDXG 78.99

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the global oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: